Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer

Neoadjuvant cisplatin-based chemotherapy for muscle-invasive bladder cancer (MIBC) is more beneficial for clinical T3/4 than clinical T2 (cT2) disease. The aim of this study was to assess whether neoadjuvant GCarbo has a survival impact on cT2 bladder cancer. We retrospectively reviewed the medical...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Koie, Takuya, Ohyama, Chikara, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Yoneyama, Tohru, Tobisawa, Yuki
Формат: Artigo
Язык:Inglês
Опубликовано: Springer US 2014
Предметы:
Original Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006118/
https://ncbi.nlm.nih.gov/pubmed/24700028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-014-0949-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы